Flublok vaccine given authorisation for temporary supply in the UK to meet public health need

Flublok®, which is licensed for use by the US FDA and has been used in the US since 2016, has been authorised for temporary supply by the MHRA, for use as part of this year’s expanded flu vaccination programme. It is only appropriate for adults aged 18 years and over.

Medicines and Healthcare products Regulatory Agency